当前位置:首页 - 行情中心 - 珈凯生物(920165) - 财务分析 - 现金流量表

珈凯生物

(920165)

  

流通市值:4.32亿  总市值:12.47亿
流通股本:1671.40万   总股本:4827.44万

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金230,397,446.23162,259,032.0571,750,982.55292,186,212.55
  收到的税费返还9,139,511.648,968,529.685,982,191.264,374,643.66
  收到其他与经营活动有关的现金3,658,514.062,374,454.44945,484.064,548,470.65
  经营活动现金流入小计243,195,471.93173,602,016.1778,678,657.87301,109,326.86
  购买商品、接受劳务支付的现金79,520,556.9654,985,159.0420,848,085.2384,709,456.65
  支付给职工以及为职工支付的现金54,871,056.3637,415,692.6623,917,569.9759,148,394.38
  支付的各项税费29,599,250.9923,665,135.1910,242,234.8636,219,257.82
  支付其他与经营活动有关的现金28,153,344.4815,720,121.038,246,157.5629,502,980.25
  经营活动现金流出小计192,144,208.79131,786,107.9263,254,047.62209,580,089.1
  经营活动产生的现金流量净额51,051,263.1441,815,908.2515,424,610.2591,529,237.76
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额1,468,481.81,373,481.8116,213.0558,256.64
  收到的其他与投资活动有关的现金570,612,277.95390,432,736.47190,233,112.64378,506,028.26
  投资活动现金流入小计572,080,759.75391,806,218.27190,349,325.69378,564,284.9
  购建固定资产、无形资产和其他长期资产支付的现金8,220,655.736,258,749.733,639,730.3514,937,617.05
  支付其他与投资活动有关的现金650,000,000360,000,000160,000,000438,000,000
  投资活动现金流出小计658,220,655.73366,258,749.73163,639,730.35452,937,617.05
  投资活动产生的现金流量净额-86,139,895.9825,547,468.5426,709,595.34-74,373,332.15
三、筹资活动产生的现金流量:
  吸收投资收到的现金127,610,115.2---
  筹资活动现金流入平衡项目0---
  筹资活动现金流入小计127,610,115.2---
  偿还债务支付的现金---200,000
  分配股利、利润或偿付利息支付的现金30,244,947.37144,083.3471,25031,162,471.99
  支付其他与筹资活动有关的现金8,896,080.61764,058607,0294,812,200
  筹资活动现金流出小计39,141,027.98908,141.34678,27936,174,671.99
  筹资活动产生的现金流量净额88,469,087.22-908,141.34-678,279-36,174,671.99
四、汇率变动对现金及现金等价物的影响-2,946.79-650,182.65-228,122.2483,978.91
五、现金及现金等价物净增加额53,377,507.5965,805,052.841,227,804.35-18,934,787.47
  加:期初现金及现金等价物余额58,996,515.8358,996,515.8358,996,515.8377,931,303.3
  期末现金及现金等价物余额112,374,023.42124,801,568.63100,224,320.1858,996,515.83
补充资料:
  净利润-37,571,648.64-66,269,300
  资产减值准备-1,000,673.25-351,400
  固定资产和投资性房地产折旧-9,652,068.96-19,178,200
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-9,652,068.96-19,178,200
  无形资产摊销-854,412.12-1,689,300
  长期待摊费用摊销-487,720.48-669,900
  处置固定资产、无形资产和其他长期资产的损失---189,100
  固定资产报废损失---26,200
  公允价值变动损失-13,972.6--24,700
  财务费用-823,146.93-332,000
  投资损失--432,736.47--506,000
  递延所得税--376,418.01-317,000
  其中:递延所得税资产减少--345,369.41-371,200
    递延所得税负债增加--31,048.6--54,200
  存货的减少--11,820,769.65-24,100
  经营性应收项目的减少--1,810,769.92-433,200
  经营性应付项目的增加-3,654,703.6--518,000
  其他---2,992,100
  现金的期末余额-124,801,568.63--
  减:现金的期初余额-58,996,515.83--
  现金及现金等价物的净增加额-65,805,052.8--18,934,787.47
公告日期2026-10-282026-08-202026-04-212026-03-20
审计意见(境内)标准无保留意见
TOP↑